Properties of purified recombinant human polyamine oxidase, PAOh1/SMO
about
Nuclear localization of human spermine oxidase isoforms - possible implications in drug response and disease etiologyBridging the gap between plant and mammalian polyamine catabolism: a novel peroxisomal polyamine oxidase responsible for a full back-conversion pathway in ArabidopsisSkin Carcinogenesis Studies Using Mouse Models with Altered Polyamines.Polyamines and cancer: implications for chemotherapy and chemopreventionMechanistic Studies of Human Spermine Oxidase: Kinetic Mechanism and pH EffectsSpermidine but not spermine is essential for hypusine biosynthesis and growth in Saccharomyces cerevisiae: spermine is converted to spermidine in vivo by the FMS1-amine oxidaseSpermine oxidase (SMO) activity in breast tumor tissues and biochemical analysis of the anticancer spermine analogues BENSpm and CPENSpm.Increased expression and cellular localization of spermine oxidase in ulcerative colitis and relationship to disease activityChemical and biochemical approaches in the study of histone methylation and demethylationStructures and Mechanism of the Monoamine Oxidase Family.Metabolic stability of alpha-methylated polyamine derivatives and their use as substitutes for the natural polyamines.Spermine oxidase SMO(PAOh1), Not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell lines.Polyamine analog TBP inhibits proliferation of human K562 chronic myelogenous leukemia cells by induced apoptosis.A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor development.Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesisActivities of DL-alpha-difluoromethylarginine and polyamine analogues against Cryptosporidium parvum infection in a T-cell receptor alpha-deficient mouse model.Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes.Oligoamine analogues in combination with 2-difluoromethylornithine synergistically induce re-expression of aberrantly silenced tumour-suppressor genes.Spermine oxidase, a polyamine catabolic enzyme that links Helicobacter pylori CagA and gastric cancer risk.Biochemical evaluation of the anticancer potential of the polyamine-based nanocarrier Nano11047Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC-11047 on small cell and non-small cell lung cancer cells.Targeting polyamine metabolism: a viable therapeutic/preventative solution for cancer?Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator.Histone deacetylase inhibition overcomes drug resistance through a miRNA-dependent mechanism.Epigenetic silencing of miR-124 prevents spermine oxidase regulation: implications for Helicobacter pylori-induced gastric cancer.Polyamine catabolism and disease.The polyamines: past, present and future.Design of polyamine-based therapeutic agents: new targets and new directionsPolyamine analogues targeting epigenetic gene regulation.Spermine oxidase: ten years after.Polyamine catabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention.Structure-function relationships in the evolutionary framework of spermine oxidase.Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes.LSD1 inhibitors: a patent review (2010-2015).(Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators.Metabolism of N-alkylated spermine analogues by polyamine and spermine oxidases.Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genesInduction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization.A simple assay for mammalian spermine oxidase: a polyamine catabolic enzyme implicated in drug response and disease.
P2860
Q24323188-E565C655-FFED-4950-8EE6-80C05A821D4CQ24651626-65BCB615-B99F-40AB-8196-2FA67DF2F1DDQ26783914-7E36657D-B28B-4AB4-8879-8D1C25F79E0BQ26864516-D9797F1D-B304-4BFA-9938-9C43E8E58F8EQ28468161-7CB2D033-76E3-4B56-8361-070B5B1C8894Q33713489-F97DD73D-5A84-4775-9A1D-3AF0743EFC43Q33718656-2D7DAEB0-EE0E-4639-A692-22D5EC197349Q33949553-F8F9837A-80BF-4D63-828C-9B65B90C4298Q34030702-0D6F2650-4EE6-4C1C-9CD6-918CF370E2E3Q34226891-46828A3B-E356-4CF0-AEB4-80E9D5F1B549Q34378351-0F838AED-1774-4C37-AAC2-0BAE2C485F25Q34457193-0C705871-D42F-460F-B042-076F0D821135Q34582662-B404CC12-8C6C-4339-9057-1C9144121536Q35190809-71055097-DAD4-4AF9-B3DA-720CCCBFD951Q35217096-A4BB5810-51EF-466B-A42F-E0F5CC01C131Q35758936-85DD8FD1-7642-4614-AC13-90B1F4C7CBF4Q35762084-07E8283C-01FF-4F02-BEB1-44CE4166C404Q35778754-54C26852-C251-4917-B2BC-D95D0CC69BF8Q35914088-8AD8576B-C9BA-458D-BB5A-97A311F1922BQ36351012-1228C633-5E92-41A7-9343-02AAED0D27EEQ36374629-CC47E2DD-8AE8-492F-AEE3-4321F62368F1Q36790732-ADBA4A14-A3B7-4BBB-855A-7BC153D56F6DQ36916921-9A2A721A-B1AB-4AE8-9F37-12FA31FC143DQ37113086-CBA641FE-3D26-4071-94DF-EB72E6859665Q37254835-AC756175-390F-4487-A5C6-4B8F819B8943Q37309826-CEF419D7-C80C-432E-AA04-7348B9B84B25Q37372519-95D4873E-BE8D-4DF7-AAD6-1F2B63744E3CQ37679969-93FFDE8C-9B96-4F2A-B91D-6BFF9ACBFDD5Q37679982-0ACD499C-0130-4727-A8B4-884A5B1E39FFQ37679985-E0C181C7-2ABE-406C-825B-7F814BC7A15AQ37910036-354718B5-C535-4B32-B9F2-274AC9A97C5AQ38114862-651B6D77-2E32-4C1D-9D4B-02B353208DA5Q38119430-6963DE70-1383-46C5-BC93-3F1ABBB78EC5Q38590435-835412D9-B815-46F0-A97C-577921073B2AQ38790899-35C6998D-ABC8-4ED2-8C52-F5B81A99338EQ39689810-4986C9A7-7C59-4AE6-BB9E-FB8DBD6AAA3AQ39763128-563E4D1A-FAE4-413B-B864-3751B29D3C7BQ39771388-B1DB090D-6CD4-43E4-BEC7-DE04B15DCF5FQ40537033-BE6834E9-7EFB-4548-8156-86BBCB734173Q40645768-753B62CA-3754-45A5-A016-F96F8FE25C2B
P2860
Properties of purified recombinant human polyamine oxidase, PAOh1/SMO
description
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Mai 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/05/16)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/05/16)
@nl
наукова стаття, опублікована в травні 2003
@uk
مقالة علمية (نشرت في 16-5-2003)
@ar
name
Properties of purified recombinant human polyamine oxidase, PAOh1/SMO
@ast
Properties of purified recombinant human polyamine oxidase, PAOh1/SMO
@en
Properties of purified recombinant human polyamine oxidase, PAOh1/SMO
@nl
type
label
Properties of purified recombinant human polyamine oxidase, PAOh1/SMO
@ast
Properties of purified recombinant human polyamine oxidase, PAOh1/SMO
@en
Properties of purified recombinant human polyamine oxidase, PAOh1/SMO
@nl
prefLabel
Properties of purified recombinant human polyamine oxidase, PAOh1/SMO
@ast
Properties of purified recombinant human polyamine oxidase, PAOh1/SMO
@en
Properties of purified recombinant human polyamine oxidase, PAOh1/SMO
@nl
P2093
P3181
P1476
Properties of purified recombinant human polyamine oxidase, PAOh1/SMO
@en
P2093
Amy Hacker
Benjamin Frydman
Robert A Casero
Wendy Devereux
Yanlin Wang
P304
P3181
P356
10.1016/S0006-291X(03)00636-3
P407
P577
2003-05-01T00:00:00Z